Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.

Kavitha Mohanasundaram Sham SanthanamRaja NatarajanHema MurugesanThilagavathy NambiBalaji ChilikuriSubramanian Nallasivan

Published in: International journal of rheumatic diseases (2022)

ChAdOx1 nCov-19 and BBV 152 were found to be safe in patients with rheumatic diseases. Fear of side effects was the major cause of vaccine hesitancy. All adverse effects were minor and self-limiting. Breakthrough infections and disease flares occurred only in a small subset of our cohort.

Keyphrases

coronavirus disease
sars cov
multiple sclerosis
cross sectional
prefrontal cortex
drug induced